Home | Help Center

Endless possibilities in academia

A method for predicting the outcome of PD1/PD-L1 inhibitors in non-small cell lung cancer

Wensong Yan1 , Shiju Yan1 , Yunhua Xu2


1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China. 2Department of Oncology, Shanghai Chest Hospital, Shanghai 200030, China.


Address correspondence to: Shiju Yan, School of Health Sciences and Engineering, University of Shanghai for Science and Technology, No.580 Jungong Road, Shanghai 200093, China. Tel: +86-18217617984. E-mail: yanshiju@usst.edu.cn.


DOI: https://doi.org/10.61189/828047gamhgw


Received January 13, 2025; Accepted April 15, 2025; Published December 31, 2025


Highlights

 ● This study introduces a novel method to predict the efficacy of PD1/PD-L1 inhibitors in non-small cell lung can-cer by extracting radiomic features from pre-treatment and post-treatment CT images. 

● Integrating biological features and radiomic features enhances predictive performance. 

● The newly proposed segmentation model achieved a dice coefficient of 90.09%, enabling accurate lesion seg-mentation.

Abstract

Objective: To propose a method for predicting immunotherapy outcome in non-small cell lung cancer based on computed tomography images before and after treatment. Methods: An improved U-net model incorporating Efficient Channel Attention was used to segment lesions. Radiomic features of lesions were extracted using PyRadiomics package and combined with biological indicators. Feature selection and dimensionality reduction were performed using linear discriminant analysis and Pearson correlation algorithms. A support vector machine was used to establish the predictive model. Results: The proposed segmentation model achieved a Dice coefficient of 90.09%, a positive predictive value of 89.23%, and an intersection over union of 82.15%, outperforming mainstream segmentation models. The proposed predictive model achieved an area under the curve of 85.05%, accuracy of 77.59%, specificity of 81.68% and sensitivity of 73.52%, all superior to models based solely on single-time computed tomography images or lacking biological features. Conclusion: The proposed method provides an effective approach for predicting the efficacy of immunotherapy in non-small cell lung cancer patients and offers a  valuable tool to support clinical decision-making.

Keywords: Immunotherapy, medical image segmentation, non-small cell lung cancer, machine learning, feature engineering

Cite

Yan WS, Yan SJ, Xu YH. A method for predicting the outcome of PD1/PD-L1 inhibitors in non-small cell lung cancer. Prog in Med Devices. 2025 Dec; 3 (4): 255-264. doi: 10.61189/828047gamhgw

[Copy]